Disclosure: this page links to GiftFromWithin.org, a site we have a commercial relationship with. If you sign up through that link we may be paid. It does not change what we say here.
Weight gain is one of the most common side effects of prescription medication, and one of the most frustrating. If you take an antidepressant, an antipsychotic, a mood stabilizer, or a corticosteroid, the scale can keep climbing even though nothing about your eating or your activity has changed. It is a hard problem to solve, because for many people the drug is doing important work. Stopping a medication that is treating a serious condition, purely to lose weight, is rarely a safe trade.
Why do medications cause weight gain?
The reasons differ by drug class, but most of them come back to appetite and metabolism. Research published in Obesity Reviews describes several routes: drugs can turn up appetite signals, change how the body stores fat, lower the amount of energy you burn at rest, and shift the makeup of the gut microbiome. Often more than one of those is happening at once.
Antidepressants (SSRIs and SNRIs)
SSRIs such as paroxetine, citalopram, and sertraline are among the most widely prescribed drugs in the world. They work well for many people with depression and anxiety. They can also come with weight gain over the long run. A large study in The BMJ found that people taking antidepressants had a 21% higher risk of gaining weight than people who were not, followed over five years. Serotonin helps regulate appetite as well as mood, so the same pathway that lifts your mood can also increase carbohydrate cravings and blunt the signal that tells you that you are full.
Atypical antipsychotics
This is the drug class with the biggest weight effect. Olanzapine and clozapine can add roughly 10 to 22 pounds (5 to 10 kg) in the first few months of treatment. Research in Lancet Psychiatry reports that with some of these drugs, up to 72% of patients gain a clinically significant amount of weight. They act on histamine H1 and serotonin 5-HT2C receptors, and both of those are involved in appetite and metabolism.
Corticosteroids
Prednisone and dexamethasone are prescribed for inflammatory and autoimmune conditions. They drive weight gain in three ways: they increase appetite, they cause the body to hold fluid, and they move fat toward the abdomen and face. Even a short course can change body composition enough to notice. Long-term use is linked to insulin resistance and metabolic syndrome.
Other medications that contribute
Several other classes are associated with weight gain: beta-blockers for high blood pressure, some anticonvulsants (valproate and gabapentin in particular), insulin and sulfonylureas for diabetes, and certain antihistamines. If you take several of these at once, the effects can stack.
The PTSD and weight gain connection
For people being treated for post-traumatic stress disorder, this can become a second health problem sitting on top of the first. PTSD treatment often means more than one weight-promoting drug at a time, such as an SSRI for depression alongside an atypical antipsychotic for intrusive symptoms. Research in the Journal of Clinical Psychiatry has documented that veterans with PTSD have much higher rates of obesity than the general population. Medication side effects are one major reason. Trauma-related changes in eating and stress physiology are another. Newer drugs, including tirzepatide and other GLP-1 receptor agonists, are now being looked at as a way to address the weight without interfering with the psychiatric treatment.
The metabolic changes these drugs cause are real and physical: more insulin resistance, altered fat storage, and disrupted hunger signaling. That is why eating better and moving more, on their own, often does not fix it. The body is being pushed in the other direction.
GLP-1 receptor agonists
GLP-1 receptor agonists are one of the more promising options here. They were developed for type 2 diabetes, and they work by copying a natural hormone that regulates appetite, insulin release, and how quickly the stomach empties. Tirzepatide targets both the GLP-1 and GIP receptors, and it has produced the strongest results in trials so far.
The SURMOUNT trials, published in the New England Journal of Medicine, reported average weight loss of 15% to 20.9% of body weight over 72 weeks, depending on the dose. Studies looking specifically at people with antipsychotic-induced weight gain are early and small. The signals are encouraging, but larger randomized trials are needed before anyone can write clinical guidelines for this group. Treat it as promising rather than settled.
Putting a plan together
Managing this well usually means working on several fronts at once, with the people prescribing your medication:
- Review the medication. Ask your prescriber whether a different drug in the same class, with a smaller weight effect, would work as well for you.
- Get nutritional support. Aim for structured help focused on metabolic health rather than a straight calorie cut.
- Move regularly. Evidence in JAMA Internal Medicine supports both aerobic exercise and resistance training for metabolic health. Pick something you can actually keep doing.
- Track the metabolic numbers. Blood glucose, a lipid panel, and waist circumference will show a problem developing before the scale explains why.
- Consider medication support. Where it is appropriate, a drug such as a GLP-1 receptor agonist can be added to counteract the metabolic effects of treatment you need to stay on.
Tell your doctor early if your weight is changing. It is much easier to act before significant metabolic damage has built up, and none of this is a reason to feel embarrassed. Effective mental health treatment and physical health are not in competition. The goal is to keep both.